Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Britannia Life Sciences Inc Com C.RLSC

RISE Life Science Corp is engaged in developing and evolving medical and adult hemp-based formulations to create general use of health and well-being products for the emerging consumer category. It derives key revenue from the United States.


CSE:RLSC - Post by User

Comment by Donlinon Jun 09, 2015 11:19am
134 Views
Post# 23810932

RE:SP in the short term

RE:SP in the short term
Totally agree and as I have mentioned before, there is no guarantee that sales will happen.  They had a Letter of Intent with India with their other prescreening device PreVU.  That has never materialized along with potential drug store opportunities.  I hope as MOM waits for the China & US drug approvals to materialize that a CDN drugstore "deal" is being worked on.  Haven't seen any update on this so just wondering.

Still amazed that with the perceived success of the SCOUT via the trial and the diabetes challenge thru out the global communities that the Canadian Diabetes and World Health Organizations have not provided any type of endorsement.  Hope they are working on these as well but again one would have thought that these would have been no-brainers.

At 8.5/9 cents something is missing from all of this but can't put my hands around it unless it's simply bad marketing practices/policies and subsequent execution processes.
Bullboard Posts